Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...
The American College of Cardiology has recommended that physicians embrace weight loss medications, such as semaglutide and tirzepatide, as first-line treatment options for patients at risk of ...
Please provide your email address to receive an email when new articles are posted on . An ACC panel states modern obesity medications may be considered as first-line therapy for treatment of obesity.
Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...
A total of 871 patient samples were retrospectively tested using the VENTANA PD-L1 (SP263) assay (Roche Diagnostics, Indianapolis, IN), including 481 enrolled patients and 390 patients who did not ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results